PURPOSE: The neuroendocrinology of female sex hormones is of great interest for a variety of neuropsychiatric disorders. In fact, estrogens and estrogen receptors (ERs) exert neuromodulatory and neuroprotective functions. Here we investigated potential targets of the ER subtype alpha that may mediate neuroprotection and focused on direct modulators and downstream executors of apoptosis. METHODS: We employed subclones of human neuroblastoma cells (SK-N-MC) stably transfected with one of the ER subtypes, ERalpha or ERbeta. Differences between the cell lines regarding the mRNA expression levels were examined by qPCR, changes on protein levels were examined by Western Blot and immunocytochemistry. Differences concerning apoptosis induction were analysed by cell survival assays which included primary rat neurons. RESULTS: In this report we show a potent protection against apoptosis-stimuli in ERalpha expressing cells compared to controls lacking ERalpha. In fact, almost a complete silencing of Caspase 3 expression in SK-ERalpha cells compared to SK-01 control transfected cells was observed. In addition, prosurvival bcl2, bag1 and bag3 expression was highly up-regulated in the presence of ERalpha. CONCLUSION: Taken together, we identified Caspase 3, BAG1 and BAG3 as key targets of ERalpha in neuronal cells that may play a role in ERalpha-mediated neuroprotection.
PURPOSE: The neuroendocrinology of female sex hormones is of great interest for a variety of neuropsychiatric disorders. In fact, estrogens and estrogen receptors (ERs) exert neuromodulatory and neuroprotective functions. Here we investigated potential targets of the ER subtype alpha that may mediate neuroprotection and focused on direct modulators and downstream executors of apoptosis. METHODS: We employed subclones of humanneuroblastoma cells (SK-N-MC) stably transfected with one of the ER subtypes, ERalpha or ERbeta. Differences between the cell lines regarding the mRNA expression levels were examined by qPCR, changes on protein levels were examined by Western Blot and immunocytochemistry. Differences concerning apoptosis induction were analysed by cell survival assays which included primary rat neurons. RESULTS: In this report we show a potent protection against apoptosis-stimuli in ERalpha expressing cells compared to controls lacking ERalpha. In fact, almost a complete silencing of Caspase 3 expression in SK-ERalpha cells compared to SK-01 control transfected cells was observed. In addition, prosurvival bcl2, bag1 and bag3 expression was highly up-regulated in the presence of ERalpha. CONCLUSION: Taken together, we identified Caspase 3, BAG1 and BAG3 as key targets of ERalpha in neuronal cells that may play a role in ERalpha-mediated neuroprotection.
Authors: Martina P Pasillas; Sarah Shields; Rebecca Reilly; Jan Strnadel; Christian Behl; Robin Park; John R Yates; Richard Klemke; Steven L Gonias; Judith A Coppinger Journal: Mol Cell Proteomics Date: 2014-07-05 Impact factor: 5.911
Authors: V Felzen; C Hiebel; I Koziollek-Drechsler; S Reißig; U Wolfrum; D Kögel; C Brandts; C Behl; T Morawe Journal: Cell Death Dis Date: 2015-07-09 Impact factor: 8.469
Authors: Jose L Labandeira-Garcia; Maria A Costa-Besada; Carmen M Labandeira; Begoña Villar-Cheda; Ana I Rodríguez-Perez Journal: Front Aging Neurosci Date: 2017-11-03 Impact factor: 5.750
Authors: Gamze Kilic; Ana I Alvarez-Mercado; Bader Zarrouki; Darren Opland; Chong Wee Liew; Laura C Alonso; Martin G Myers; Jean-Christophe Jonas; Vincent Poitout; Rohit N Kulkarni; Franck Mauvais-Jarvis Journal: PLoS One Date: 2014-02-03 Impact factor: 3.240
Authors: Jose L Labandeira-García; Pablo Garrido-Gil; Jannette Rodriguez-Pallares; Rita Valenzuela; Ana Borrajo; Ana I Rodríguez-Perez Journal: Front Neuroanat Date: 2014-07-08 Impact factor: 3.856